Skip to main content

Unraveling the mystery of preferential degeneration of midbrain neurons in neurodegenerative diseases

Project description

Unveiling the mechanism of neurodegeneration in Parkinson's disease

In Parkinson's disease (PD), oxidised dopamine and alpha-synuclein serve as key mediators of mitochondrial and lysosomal dysfunction in midbrain dopaminergic neurons that preferentially degenerate in this progressive movement disorder. The working hypothesis of the EU-funded oxDOPAMINE project is that oxidation of dopamine aberrantly increases in PD. Scientists will investigate pathways of dopamine oxidation that predisposes human neurons to selective vulnerability and degeneration. Based on recent data implicating defective synaptic dopamine metabolism and iron dyshomeostasis in the oxidation of dopamine early in disease pathogenesis, they will study disorders associated with iron accumulation and progressive dopamine neuron degeneration to find common pathogenic mechanisms. Results may lead to novel strategies for restoring synaptic dysfunction and iron homeostasis as a means of preventing neurodegeneration.

Call for proposal

ERC-2020-STG
See other projects for this call

Host institution

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Address
Geschwister Scholl Platz 1
80539 Muenchen
Germany
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 500 000

Beneficiaries (1)

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 1 500 000
Address
Geschwister Scholl Platz 1
80539 Muenchen
Activity type
Higher or Secondary Education Establishments